Summary:
To evaluate the safety and effectiveness of an investigational hormone contraceptive therapy for the treatment of menstrual-related migraines.
Study length:
5 visits over approximately 20 weeks
Qualified Participants Must:
• Be a female between 18-34 years of age
•
Be a non-smoker
•
Have regular menstrual cycles
•
Experience migraines during or around most of your cycles
•
Not currently be taking any hormonal contraceptives or are willing to come off of your current contraceptive regimen
•
Be interested in participating in a research study
Qualified Participants May Receive:
Investigational medication and study related medical exams at no cost.